“…SIADH may result secondary to malignant neoplasms, nonmalignant pulmonary disease, and various disorders of the central nervous system (Liu, Mittmann, Knowles, & Shear, 1996). Multiple case studies and small sample investigations (e.g., Christe & Vogt, 1999; John, Perreault, Tao, & Blew, 1997; Kelly, Robinson, & Beringer, 1999; Levsky & Schwartz, 1998; Spigset & Mjorndal, 1997; Spigset, Wilhelmsson, Mjorndal, & Eriksson, 2000) have identified the onset of hyponatremia secondary to SIADH in association with SSRI therapy. Most of these reports have involved geriatric patients.…”